Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A combined ligand, combined biomimetic chromatography medium and its preparation method and application

A combined biomimetic layer technology, applied in the field of biomimetic chromatography, can solve problems such as single ligand structure, low antibody selectivity, and antibody difficulty, and achieve the goal of improving elution conditions, strengthening hydrophobic interaction, and reducing elution difficulty Effect

Active Publication Date: 2019-09-10
ZHEJIANG UNIV
View PDF10 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, HCIC ligands also have some defects. The ligand structure is relatively simple, and the selectivity for antibodies is not high. For antibodies from different sources, a lot of process optimization is required, and it is difficult to separate high-purity antibodies from complex feed solutions.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A combined ligand, combined biomimetic chromatography medium and its preparation method and application
  • A combined ligand, combined biomimetic chromatography medium and its preparation method and application
  • A combined ligand, combined biomimetic chromatography medium and its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0054] Embodiment 1: Preparation of combined ligand

[0055] With the help of computer molecular simulation, analyze and evaluate the key residues of protein A and antibody Fc binding site, screen and design the combinatorial ligand of tripeptide-heterocyclic small molecule, whose sequence is phenylalanine-tyramine Acid-glutamic acid-5-aminobenzimidazole.

[0056] Combined ligand, the structural formula is as follows:

[0057]

[0058] The combinatorial ligand can be synthesized by the chemical synthesis method in the prior art, and the combinatorial ligand in this example is entrusted to China Peptide Biochemical Co., Ltd. to prepare it.

[0059] Carry out high performance liquid chromatography characterization for the combined ligand in embodiment 1, such as figure 1 shown.

Embodiment 2

[0060] Example 2: Preparation of Combined Biomimetic Chromatography Medium

[0061] Take 5.0 g of drained agarose gel, add 5.0 g of 20% (v / v) dimethyl sulfoxide, 2.5 g of allyl bromide and 1.0 g of sodium hydroxide, activate it on a shaker at 150 rpm at 30 ° C for 24 hours, and pump Filter and wash with deionized water to obtain an activated chromatography matrix.

[0062] Mix the activated chromatographic matrix, 10.0g 50% (v / v) acetone and 1.5g N-bromosuccinimide for bromoalcoholization, react on a shaking table at 150rpm at 30°C for 3h, filter with suction, and use deionized Washing with water yields a bromoalcoholated substrate.

[0063] Mix 2.5g dimethyl sulfoxide and 5.0g 1M sodium carbonate buffer, add 0.5g phenylalanine-tyrosine-glutamic acid-5-aminobenzimidazolidine, fully dissolve, then add bromoalcohol The chromatographic matrix was reacted on a shaking table at 150 rpm at 30°C for 12 hours, and was repeatedly washed with deionized water, 0.1M HCl, and 0.1M NaOH t...

Embodiment 3

[0067] Example 3: Preparation of Combined Biomimetic Chromatography Medium

[0068] Take 5.0 g of drained agarose gel, add 2.5 g of 20% (v / v) dimethyl sulfoxide, 0.5 g of allyl bromide and 0.5 g of sodium hydroxide, activate it on a shaker at 150 rpm at 30 ° C for 24 hours, and pump Filter and wash with deionized water to obtain an activated chromatography matrix.

[0069] Mix the activated chromatographic matrix, 5.0g 50% (v / v) acetone and 0.5g N-bromosuccinimide for bromoalcoholization, react on a shaking table at 150rpm at 30°C for 1h, filter with suction, and use deionized Washing with water yields a bromoalcoholated substrate.

[0070] Mix 3.0g dimethyl sulfoxide and 5.0g 1M sodium carbonate buffer, add 0.5g phenylalanine-tyrosine-glutamic acid-5-aminobenzimidazolidine, fully dissolve, then add bromoalcohol The chromatographic matrix was reacted on a shaking table at 150 rpm at 30°C for 8 hours, and was repeatedly washed with deionized water, 0.1M HCl, and 0.1M NaOH to ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
adsorption capacityaaaaaaaaaa
adsorption capacityaaaaaaaaaa
adsorption capacityaaaaaaaaaa
Login to View More

Abstract

The invention relates to a combined ligand, a combined bionic chromatography medium and a preparation method and application thereof. The combined bionic chromatography medium uses hydrophilic porousmicrospheres as chromatography matrix, is activated by allyl bromide, is brominated and alcoholized by N-bromosuccinimide, and then is coupled with the combined ligand. The sequence of the combined ligand is phenylalanine-tyrosine-glutamic acid-5-aminobenzimidazole. The combined bionic chromatography medium has two functional groups including phenylalanine-tyrosine-glutamic acid tripeptide and aminobenzimidazole, introduces a hydrophobicity charge-inducing ligand while retaining the high selectivity characteristic of a polypeptide ligand to an antibody, makes elution conditions milder, and achieves effective antibody isolation.

Description

technical field [0001] The invention relates to the field of bionic chromatography, in particular to a combination ligand, a combination bionic chromatography medium and a preparation method and application thereof. Background technique [0002] Antibodies have strong targeting and high biocompatibility, and have great potential to be developed into drugs for the treatment of cancer. With the continuous development of antibody engineering, the scale of upstream antibody expression and preparation continues to increase, and the development of efficient downstream separation and purification technology is the key to the development of the antibody industry. [0003] At present, protein A affinity chromatography is the most commonly used antibody capture method, which has high selectivity, but the medium is expensive, the elution conditions are harsh, and there is a risk of ligand shedding. Therefore, the development of alternative technologies has become a current hotspot, an...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K5/087C07K16/00C07K1/22B01D15/08
Inventor 姚善泾林东强张其磊邹徐俊卢慧丽
Owner ZHEJIANG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com